In a significant announcement, President Trump is set to reveal a new drug pricing deal with AstraZeneca, following a similar agreement with Pfizer. This move aims to lower U.S. drug prices and pressure major drugmakers to bring manufacturing back to America. Will it lead to real savings for taxpayers?
In a groundbreaking announcement, President Trump reveals a deal with AstraZeneca to lower drug prices for Americans, especially low-income individuals. With a new website set to launch, this initiative aims to make prescriptions more accessible than ever.
Eli Lilly announces a groundbreaking $5 billion investment in a new manufacturing plant near Richmond, aimed at boosting U.S. production of essential pharmaceutical ingredients.
President Trump announces significant tariffs on pharmaceutical imports to revive U.S. manufacturing. Will this bold move shake the global drug market and impact upcoming midterms?
